Literature DB >> 14523460

Successful treatment of hyperuricemia with low doses of recombinant urate oxidase in four patients with hematologic malignancy and tumor lysis syndrome.

M Hummel, D Buchheidt, S Reiter, J Bergmann, R Hofheinz, R Hehlmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14523460     DOI： 10.1038/sj.leu.2403161

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  3 in total

Review 1.  Serum uric acid-lowering therapies: where are we heading in management of hyperuricemia and the potential role of uricase.

Authors:  John S Bomalaski; Mike A Clark
Journal:  Curr Rheumatol Rep       Date:  2004-06       Impact factor: 4.592

2.  Relationship of circulating total homocysteine and C-reactive protein to trabecular bone in postmenopausal women.

Authors:  Shilpa N Bhupathiraju; D Lee Alekel; Jeanne W Stewart; Laura N Hanson; Kristine M Shedd; Manju B Reddy; Kathy B Hanson; Marta D Van Loan; Ulrike Genschel; Kenneth J Koehler
Journal:  J Clin Densitom       Date:  2007-07-26       Impact factor: 2.617

Review 3.  Prevention and treatment of tumor lysis syndrome, and the efficacy and role of rasburicase.

Authors:  Nael Alakel; Jan Moritz Middeke; Johannes Schetelig; Martin Bornhäuser
Journal:  Onco Targets Ther       Date:  2017-02-02       Impact factor: 4.147
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.